AMGN logo

Amgen (AMGN) Operating profit

annual operating profit:

$7.26B-$639.00M(-8.09%)
December 31, 2024

Summary

  • As of today (April 16, 2025), AMGN annual operating income is $7.26 billion, with the most recent change of -$639.00 million (-8.09%) on December 31, 2024.
  • During the last 3 years, AMGN annual operating profit has fallen by -$1.89 billion (-20.63%).
  • AMGN annual operating profit is now -29.28% below its all-time high of $10.26 billion, reached on December 31, 2018.

Performance

AMGN Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNincome statement metrics

quarterly operating profit:

$2.31B+$264.00M(+12.90%)
December 31, 2024

Summary

  • As of today (April 16, 2025), AMGN quarterly operating income is $2.31 billion, with the most recent change of +$264.00 million (+12.90%) on December 31, 2024.
  • Over the past year, AMGN quarterly operating profit has increased by +$1.04 billion (+81.83%).
  • AMGN quarterly operating profit is now -18.40% below its all-time high of $2.83 billion, reached on June 30, 2018.

Performance

AMGN quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNincome statement metrics

TTM operating profit:

$7.26B+$1.04B(+16.73%)
December 31, 2024

Summary

  • As of today (April 16, 2025), AMGN TTM operating income is $7.26 billion, with the most recent change of +$1.04 billion (+16.73%) on December 31, 2024.
  • Over the past year, AMGN TTM operating profit has dropped by -$639.00 million (-8.09%).
  • AMGN TTM operating profit is now -29.54% below its all-time high of $10.30 billion, reached on June 30, 2017.

Performance

AMGN TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMGNincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

AMGN Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.1%+81.8%-8.1%
3 y3 years-20.6%+0.3%-20.6%
5 y5 years-25.0%+12.8%-24.1%

AMGN Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-24.1%at low-13.9%+133.2%-24.7%+17.2%
5 y5-year-25.0%at low-13.9%+133.2%-24.7%+17.2%
alltimeall time-29.3%>+9999.0%-18.4%+3214.6%-29.5%>+9999.0%

Amgen Operating profit History

DateAnnualQuarterlyTTM
Dec 2024
$7.26B(-8.1%)
$2.31B(+12.9%)
$7.26B(+16.7%)
Sep 2024
-
$2.05B(+7.2%)
$6.22B(+0.4%)
Jun 2024
-
$1.91B(+92.6%)
$6.19B(-11.1%)
Mar 2024
-
$991.00M(-22.0%)
$6.97B(-11.8%)
Dec 2023
$7.90B(-17.4%)
$1.27B(-37.1%)
$7.90B(-10.8%)
Sep 2023
-
$2.02B(-24.7%)
$8.86B(-6.7%)
Jun 2023
-
$2.68B(+39.7%)
$9.49B(+5.7%)
Mar 2023
-
$1.92B(-13.9%)
$8.99B(-6.1%)
Dec 2022
$9.57B(+4.6%)
$2.23B(-16.2%)
$9.57B(-0.8%)
Sep 2022
-
$2.66B(+22.2%)
$9.64B(+3.0%)
Jun 2022
-
$2.18B(-13.0%)
$9.36B(-1.7%)
Mar 2022
-
$2.50B(+8.5%)
$9.52B(+4.1%)
Dec 2021
$9.14B(+0.1%)
$2.30B(-3.1%)
$9.14B(+3.3%)
Sep 2021
-
$2.38B(+1.9%)
$8.85B(-0.8%)
Jun 2021
-
$2.33B(+9.6%)
$8.92B(+0.1%)
Mar 2021
-
$2.13B(+6.0%)
$8.91B(-2.5%)
Dec 2020
$9.14B(-5.5%)
$2.01B(-18.1%)
$9.14B(-0.4%)
Sep 2020
-
$2.45B(+5.6%)
$9.18B(-0.2%)
Jun 2020
-
$2.32B(-1.4%)
$9.20B(-3.7%)
Mar 2020
-
$2.35B(+15.0%)
$9.56B(-1.2%)
Dec 2019
$9.67B(-5.7%)
$2.05B(-17.3%)
$9.67B(-3.3%)
Sep 2019
-
$2.48B(-7.5%)
$10.01B(+1.6%)
Jun 2019
-
$2.68B(+8.3%)
$9.86B(-1.5%)
Mar 2019
-
$2.47B(+3.8%)
$10.01B(-2.5%)
Dec 2018
$10.26B(+2.9%)
$2.38B(+2.5%)
$10.26B(+1.4%)
Sep 2018
-
$2.32B(-18.0%)
$10.13B(-1.1%)
Jun 2018
-
$2.83B(+3.9%)
$10.24B(+1.3%)
Mar 2018
-
$2.73B(+21.4%)
$10.11B(+1.4%)
Dec 2017
$9.97B(+1.8%)
$2.25B(-8.0%)
$9.97B(-2.3%)
Sep 2017
-
$2.44B(-9.6%)
$10.21B(-0.9%)
Jun 2017
-
$2.70B(+4.1%)
$10.30B(+3.2%)
Mar 2017
-
$2.59B(+4.3%)
$9.98B(+1.9%)
Dec 2016
$9.79B(+15.6%)
$2.48B(-1.7%)
$9.79B(+4.8%)
Sep 2016
-
$2.53B(+6.2%)
$9.34B(+2.1%)
Jun 2016
-
$2.38B(-0.9%)
$9.15B(+3.4%)
Mar 2016
-
$2.40B(+18.2%)
$8.85B(+4.5%)
Dec 2015
$8.47B(+36.8%)
$2.03B(-13.1%)
$8.47B(+7.3%)
Sep 2015
-
$2.34B(+12.7%)
$7.90B(+12.4%)
Jun 2015
-
$2.08B(+2.7%)
$7.02B(+2.5%)
Mar 2015
-
$2.02B(+38.6%)
$6.85B(+10.6%)
Dec 2014
$6.19B(+5.5%)
$1.46B(-0.5%)
$6.19B(+4.6%)
Sep 2014
-
$1.47B(-22.9%)
$5.92B(-3.6%)
Jun 2014
-
$1.90B(+39.4%)
$6.14B(+6.1%)
Mar 2014
-
$1.36B(+14.9%)
$5.79B(-1.3%)
Dec 2013
$5.87B(+5.2%)
$1.19B(-29.7%)
$5.87B(+1.7%)
Sep 2013
-
$1.69B(+8.9%)
$5.77B(+4.8%)
Jun 2013
-
$1.55B(+7.5%)
$5.50B(-0.7%)
Mar 2013
-
$1.44B(+32.5%)
$5.54B(-0.6%)
Dec 2012
$5.58B(+29.3%)
$1.09B(-23.5%)
$5.58B(-1.3%)
Sep 2012
-
$1.42B(-10.4%)
$5.65B(+18.9%)
Jun 2012
-
$1.59B(+7.6%)
$4.75B(+5.7%)
Mar 2012
-
$1.48B(+27.1%)
$4.50B(+4.3%)
Dec 2011
$4.31B(-22.2%)
$1.16B(+121.3%)
$4.31B(+2.2%)
Sep 2011
-
$525.00M(-60.6%)
$4.22B(-18.4%)
Jun 2011
-
$1.33B(+3.0%)
$5.17B(-3.5%)
Mar 2011
-
$1.29B(+21.1%)
$5.36B(-3.4%)
Dec 2010
$5.54B(+0.7%)
$1.07B(-27.8%)
$5.54B(-1.0%)
Sep 2010
-
$1.48B(-2.5%)
$5.60B(-2.2%)
Jun 2010
-
$1.52B(+2.4%)
$5.73B(+1.1%)
Mar 2010
-
$1.48B(+31.9%)
$5.67B(+2.9%)
Dec 2009
$5.51B(+5.6%)
$1.12B(-30.0%)
$5.51B(-0.3%)
Sep 2009
-
$1.60B(+10.2%)
$5.52B(+2.3%)
Jun 2009
-
$1.46B(+10.3%)
$5.40B(+5.4%)
Mar 2009
-
$1.32B(+16.2%)
$5.12B(-1.8%)
Dec 2008
$5.21B(+9.1%)
$1.14B(-23.3%)
$5.21B(-2.4%)
Sep 2008
-
$1.48B(+25.8%)
$5.34B(+10.3%)
Jun 2008
-
$1.18B(-16.7%)
$4.84B(+1.0%)
Mar 2008
-
$1.42B(+11.8%)
$4.79B(+0.3%)
Dec 2007
$4.78B(-5.8%)
$1.27B(+28.8%)
$4.78B(-16.6%)
Sep 2007
-
$983.00M(-13.0%)
$5.73B(-5.6%)
Jun 2007
-
$1.13B(-19.3%)
$6.07B(-4.2%)
Mar 2007
-
$1.40B(-36.9%)
$6.34B(+2.7%)
Dec 2006
$5.07B(+4.6%)
$2.22B(+67.9%)
$6.17B(+22.1%)
Sep 2006
-
$1.32B(-5.3%)
$5.05B(+0.5%)
Jun 2006
-
$1.40B(+13.1%)
$5.03B(+2.1%)
Mar 2006
-
$1.23B(+12.1%)
$4.93B(+1.6%)
Dec 2005
$4.85B(+24.2%)
$1.10B(-15.2%)
$4.85B(-7.1%)
Sep 2005
-
$1.30B(+0.4%)
$5.22B(+18.2%)
Jun 2005
-
$1.29B(+11.9%)
$4.42B(+6.9%)
Mar 2005
-
$1.16B(-21.5%)
$4.13B(+5.8%)
Dec 2004
$3.90B
$1.47B(+198.2%)
$3.90B(+22.6%)
Sep 2004
-
$494.00M(-50.9%)
$3.18B(-10.2%)
DateAnnualQuarterlyTTM
Jun 2004
-
$1.01B(+8.5%)
$3.55B(+5.7%)
Mar 2004
-
$928.00M(+22.9%)
$3.36B(+8.6%)
Dec 2003
$3.09B(+40.1%)
$755.00M(-11.9%)
$3.09B(+3.5%)
Sep 2003
-
$857.00M(+4.9%)
$2.99B(+12.1%)
Jun 2003
-
$817.10M(+23.4%)
$2.66B(+10.5%)
Mar 2003
-
$662.20M(+1.7%)
$2.41B(+9.3%)
Dec 2002
$2.21B(+44.1%)
$651.10M(+22.0%)
$2.21B(+25.0%)
Sep 2002
-
$533.70M(-5.5%)
$1.76B(+4.6%)
Jun 2002
-
$564.80M(+23.5%)
$1.69B(+7.3%)
Mar 2002
-
$457.40M(+118.7%)
$1.57B(+2.7%)
Dec 2001
$1.53B(+11.9%)
$209.10M(-54.2%)
$1.53B(-5.3%)
Sep 2001
-
$456.20M(+1.5%)
$1.62B(+4.4%)
Jun 2001
-
$449.40M(+7.9%)
$1.55B(+6.2%)
Mar 2001
-
$416.50M(+40.9%)
$1.46B(+3.4%)
Dec 2000
$1.37B(+3.3%)
$295.60M(-23.7%)
$1.41B(-2.4%)
Sep 2000
-
$387.60M(+8.2%)
$1.45B(+2.3%)
Jun 2000
-
$358.30M(-2.9%)
$1.41B(+1.5%)
Mar 2000
-
$368.90M(+11.6%)
$1.39B(+5.0%)
Dec 1999
$1.32B(+18.5%)
$330.60M(-7.0%)
$1.32B(+2.5%)
Sep 1999
-
$355.60M(+5.6%)
$1.29B(+5.1%)
Jun 1999
-
$336.80M(+11.5%)
$1.23B(+4.6%)
Mar 1999
-
$302.00M(+1.3%)
$1.18B(+5.1%)
Dec 1998
$1.12B(+20.2%)
$298.00M(+1.8%)
$1.12B(+7.2%)
Sep 1998
-
$292.80M(+3.5%)
$1.04B(+7.8%)
Jun 1998
-
$282.80M(+15.5%)
$967.70M(+2.5%)
Mar 1998
-
$244.80M(+9.9%)
$943.90M(+1.5%)
Dec 1997
$930.30M(+1.6%)
$222.80M(+2.5%)
$930.30M(-1.2%)
Sep 1997
-
$217.30M(-16.1%)
$942.00M(-1.8%)
Jun 1997
-
$259.00M(+12.0%)
$959.10M(+2.3%)
Mar 1997
-
$231.20M(-1.4%)
$937.90M(+4.1%)
Dec 1996
$916.00M(+20.4%)
$234.50M(+0.0%)
$901.10M(+3.9%)
Sep 1996
-
$234.40M(-1.4%)
$867.30M(+3.1%)
Jun 1996
-
$237.80M(+22.3%)
$841.00M(+5.4%)
Mar 1996
-
$194.40M(-3.1%)
$798.10M(+4.9%)
Dec 1995
$760.80M(+8.9%)
$200.70M(-3.6%)
$760.80M(+1.4%)
Sep 1995
-
$208.10M(+6.8%)
$750.40M(+3.3%)
Jun 1995
-
$194.90M(+24.1%)
$726.40M(+3.1%)
Mar 1995
-
$157.10M(-17.4%)
$704.50M(+0.8%)
Dec 1994
$698.50M(+26.7%)
$190.30M(+3.4%)
$698.60M(+8.1%)
Sep 1994
-
$184.10M(+6.4%)
$646.20M(+5.8%)
Jun 1994
-
$173.00M(+14.4%)
$610.90M(+5.8%)
Mar 1994
-
$151.20M(+9.6%)
$577.60M(+4.8%)
Dec 1993
$551.20M(+10.7%)
$137.90M(-7.3%)
$551.30M(-9.8%)
Sep 1993
-
$148.80M(+6.5%)
$611.50M(+5.2%)
Jun 1993
-
$139.70M(+11.8%)
$581.40M(+7.9%)
Mar 1993
-
$124.90M(-37.0%)
$538.60M(+8.1%)
Dec 1992
$498.10M(+303.6%)
$198.10M(+66.9%)
$498.10M(+30.4%)
Sep 1992
-
$118.70M(+22.5%)
$381.90M(+16.8%)
Jun 1992
-
$96.90M(+14.8%)
$326.90M(+109.8%)
Mar 1992
-
$84.40M(+3.1%)
$155.80M(+26.4%)
Dec 1991
$123.40M(+141.5%)
$81.90M(+28.6%)
$123.30M(+962.9%)
Sep 1991
-
$63.70M(-185.8%)
$11.60M(-131.8%)
Jun 1991
-
-$74.20M(-243.0%)
-$36.50M(-171.4%)
Mar 1991
-
$51.90M(-274.2%)
$51.10M(+421.4%)
Mar 1991
$51.10M(+75.6%)
-
-
Dec 1990
-
-$29.80M(-291.0%)
$9.80M(-80.9%)
Sep 1990
-
$15.60M(+16.4%)
$51.30M(+26.4%)
Jun 1990
-
$13.40M(+26.4%)
$40.60M(+40.5%)
Mar 1990
$29.10M(-706.3%)
$10.60M(-9.4%)
$28.90M(-164.9%)
Dec 1989
-
$11.70M(+138.8%)
-$44.50M(+27.5%)
Sep 1989
-
$4.90M(+188.2%)
-$34.90M(+71.1%)
Jun 1989
-
$1.70M(-102.7%)
-$20.40M(+325.0%)
Mar 1989
-$4.80M(-14.3%)
-$62.80M(-394.8%)
-$4.80M(-135.3%)
Dec 1988
-
$21.30M(+9.8%)
$13.60M(+130.5%)
Sep 1988
-
$19.40M(+12.1%)
$5.90M(-755.6%)
Jun 1988
-
$17.30M(-139.0%)
-$900.00K(-83.9%)
Mar 1988
-$5.60M(+300.0%)
-$44.40M(-426.5%)
-$5.60M(-132.7%)
Dec 1987
-
$13.60M(+7.9%)
$17.10M(+51.3%)
Sep 1987
-
$12.60M(0.0%)
$11.30M(+135.4%)
Jun 1987
-
$12.60M(-158.1%)
$4.80M(-469.2%)
Mar 1987
-$1.40M(+55.6%)
-$21.70M(-378.2%)
-$1.30M(-127.7%)
Dec 1986
-
$7.80M(+27.9%)
$4.70M(+135.0%)
Sep 1986
-
$6.10M(-6.2%)
$2.00M(-41.2%)
Jun 1986
-
$6.50M(-141.4%)
$3.40M(-950.0%)
Mar 1986
-$900.00K(-91.2%)
-$15.70M(-407.8%)
-$400.00K(-150.0%)
Dec 1985
-
$5.10M(-32.0%)
$800.00K(-129.6%)
Sep 1985
-
$7.50M(+177.8%)
-$2.70M(-69.0%)
Jun 1985
-
$2.70M(-118.6%)
-$8.70M(-17.1%)
Mar 1985
-$10.20M(+24.4%)
-$14.50M(-1006.3%)
-$10.50M(+66.7%)
Dec 1984
-
$1.60M(+6.7%)
-$6.30M(-20.3%)
Sep 1984
-
$1.50M(+66.7%)
-$7.90M(-16.0%)
Jun 1984
-
$900.00K(-108.7%)
-$9.40M(-8.7%)
Mar 1984
-$8.20M
-$10.30M
-$10.30M

FAQ

  • What is Amgen annual operating income?
  • What is the all time high annual operating profit for Amgen?
  • What is Amgen annual operating profit year-on-year change?
  • What is Amgen quarterly operating income?
  • What is the all time high quarterly operating profit for Amgen?
  • What is Amgen quarterly operating profit year-on-year change?
  • What is Amgen TTM operating income?
  • What is the all time high TTM operating profit for Amgen?
  • What is Amgen TTM operating profit year-on-year change?

What is Amgen annual operating income?

The current annual operating profit of AMGN is $7.26B

What is the all time high annual operating profit for Amgen?

Amgen all-time high annual operating income is $10.26B

What is Amgen annual operating profit year-on-year change?

Over the past year, AMGN annual operating income has changed by -$639.00M (-8.09%)

What is Amgen quarterly operating income?

The current quarterly operating profit of AMGN is $2.31B

What is the all time high quarterly operating profit for Amgen?

Amgen all-time high quarterly operating income is $2.83B

What is Amgen quarterly operating profit year-on-year change?

Over the past year, AMGN quarterly operating income has changed by +$1.04B (+81.83%)

What is Amgen TTM operating income?

The current TTM operating profit of AMGN is $7.26B

What is the all time high TTM operating profit for Amgen?

Amgen all-time high TTM operating income is $10.30B

What is Amgen TTM operating profit year-on-year change?

Over the past year, AMGN TTM operating income has changed by -$639.00M (-8.09%)
On this page